Xvivo Perfusion AB (publ) (STO:XVIVO)

Xvivo Perfusion AB Revenue

Xvivo Perfusion AB had revenue of 252.56M SEK in the quarter ending September 30, 2026, with 33.53% growth. This brings the company's total for the last twelve months to 958.65M, up 17.83% year-over-year. In the year 2025, Xvivo Perfusion AB had annual revenue of 812.17M, down -1.25%. That makes Xvivo Perfusion AB the 22,832nd largest company in the world by revenue and 293rd in Sweden.

• Revenue (ttm): 958.65M
• Revenue Growth: +17.83%
• P/S Ratio: 6.60
• Revenue / Employee: 4.63M
• Employees: 207
• Market Cap: 6.33B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Thoracic 509.32M 62.7%
• Abdominal 225.32M 27.7%
• Services 77.53M 9.5%

By Geography

Chart

• USA 427.88M 52.7%
• EMEA Excluding Sweden 306.13M 37.7%
• APAC 49.20M 6.1%
• Americas, Excl USA 22.26M 2.7%
• Sweden 6.69M 0.8%

Fiscal year ended Dec 31, 2025 See the full Xvivo Perfusion AB breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	812.17M	-10.25M	-1.25%
Dec 31, 2024	822.42M	224.87M	37.63%
Dec 31, 2023	597.54M	182.25M	43.88%
Dec 31, 2022	415.29M	156.91M	60.73%
Dec 31, 2021	258.39M	78.53M	43.66%
Dec 31, 2020	179.86M	-40.98M	-18.55%
Dec 31, 2019	220.84M	32.97M	17.55%
Dec 31, 2018	187.87M	39.53M	26.65%
Dec 31, 2017	148.34M	10.17M	7.36%
Dec 31, 2016	138.18M	17.93M	14.91%
Dec 31, 2015	120.25M	35.54M	41.96%
Dec 31, 2014	84.70M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Oct 22, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment and geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Nov 2, 2026

Data Sources Report a data error